If this report on 'implementing FDA approved, non-invasive screening technologies', that's due to be provided by the end of May, to the Appropriation Committees on both sides of the House of Congress, names 4DMedical by name, then it's pretty much a done deal.
45 days to go.
- Forums
- ASX - By Stock
- Research
If this report on 'implementing FDA approved, non-invasive...
-
- There are more pages in this discussion • 508 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DX (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.0¢ |
Change
0.010(2.22%) |
Mkt cap ! $188.8M |
Open | High | Low | Value | Volume |
45.0¢ | 46.0¢ | 44.5¢ | $90.34K | 198.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5365 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 44937 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5365 | 0.445 |
1 | 45977 | 0.435 |
6 | 78361 | 0.430 |
3 | 35960 | 0.425 |
5 | 39820 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 44937 | 3 |
0.470 | 6067 | 1 |
0.475 | 7501 | 1 |
0.480 | 30635 | 2 |
0.500 | 22110 | 3 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online